XOMA (XOMA) Reports Improvement in Diabetes and Inflammatory Measures in Animal Model With XOMA 052
Tweet Send to a Friend
XOMA Ltd. (Nasdaq: XOMA) announced the presentation of new preclinical results with XOMA 052 in the diet-induced obesity mouse model ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
